Improving on AUC. Presenter Disclosure Information. Objectives 3/13/2014. Cornelia Anderson BSN, RN. No Disclosures

Size: px
Start display at page:

Download "Improving on AUC. Presenter Disclosure Information. Objectives 3/13/2014. Cornelia Anderson BSN, RN. No Disclosures"

Transcription

1 Improving on AUC Presenter Disclosure Information Cornelia Anderson BSN, RN To following relationships exist related to this presentation: No Disclosures Objectives Discuss History & Purpose of AUC Discuss key data collection points that affect AUC Indication Demonstrate knowledge of AUC Indications through participation with ARS Discuss areas of potential for quality improvement Discuss the relationship between PCI Indication and the AUC Indication 1

2 History of AUC History of AUC Focus of the AUC Appropriate use criteria are intended to assist patients and clinicians, but are not intended to diminish the acknowledged difficulty or uncertainty of clinical decision making and cannot act as substitutes for sound clinical judgment and practice experience Appropriate Use Criteria for Coronary Revascularization Focused Update pg 4 2

3 What is Appropriate? Coronary revascularization is appropriate when the expected benefits, in terms of survival or health outcomes exceed the expected negative consequences of the procedure Appropriate Use Criteria for Coronary Revascularization Focused Update pg 4 AUC Indication in JACC A = Appropriate U = Uncertain I = Inappropriate AUC Indication on the Dashboard 3

4 Patients WITHOUT ACS Over 70 variables reviewed for the AUC some of the most weighted are: CAD Presentation Anginal Classification Non-invasive testing Anti-Ischemic Therapy Coronary Anatomy disease Pre-procedure LVEF Case Study: AUC Indication 16 What is the CAD involvement? 4

5 What is the CAD Presentation? What is the Anginal Classification? What is the Risk/Extent of Ischemia? 5

6 What is the level of Anti-Ischemic therapy? Why is the procedure Uncertain? A clinical scenario for which the likelihood that coronary revascularization will improve health outcomes or survival is uncertain Appropriate Use Criteria for Coronary Revascularization Focused Update pg 3 What does it mean? Uncertain indications..reflect clinical scenarios that are reasonable for performing revascularization, but additional clinical factors should be considered or further research is needed to more definitively define the benefits of treatment for patients Appropriate Use Criteria for Coronary Revascularization Focused Update pg 3 6

7 What if we failed to CODE key information? What if critical info was OMITTED from the medical record? What if there was MORE to the story? 7

8 Did we document all CAD? Did we document all CAD? Was the correct Risk/Extent of ischemia identified? 8

9 Was the patient on additional Anti- Ischemic medical therapy? Focus Areas Work with medical staff to document consistently Education to the definitions Location of information in the medical record Code scenario s consistently Use the dashboard to review and understand procedure ratings Review and Evaluate patient need for PCI Patients WITH ACS The Link between Stable & Unstable and the AUC Indication 9

10 PCI Indications Stable or Unstable PCI >12hrs PCI for STEMI (Unstable Unstable, >12hrs from Sx onset) PCI for STEMI (Stable Stable, >12hrs from Sx onset PCI after Thrombolytics PCI for STEMI (stable after successful full-dose lytics) Rescue PCI for STEMI (after failed full-dose lytics) AUC definition of Unstable Persistent ischemic symptoms Severe HF Hemodynamic instability Electrical Instability AUC definition for Stable No recurrent ischemia No Heart Failure No Electrical Instability 10

11 Important! Pre-Procedure LVEF The Link between the PCI Indication and the AUC Indication PCI for STEMI >12hrs & AUC Persistent ischemic symptoms Hemodynamic instability Electrical Instability Severe HF 11

12 PCI for STEMI >12hrs & AUC No recurrent ischemia No Heart Failure No Electrical Instability PCI for STEMI after lytics & AUC Pre-Procedure Procedure LVEF 50% PCI for STEMI after lytics & AUC Pre-Procedure Procedure LVEF < 50% 12

13 Focus Areas Work with medical staff to document consistently Education to the definitions Location of information in the medical record Code scenario s consistently Use the dashboard to review and understand procedure ratings Accurately account for patient symptoms in the PCI Indication Review and evaluate patient need for PCI Plan * Act * Do 13

2/26/2013. Appropriateness Use Criteria (Drilldown) Disclosures. Tony Hermann has nothing to disclose. Mark Hutcheson has nothing to disclose

2/26/2013. Appropriateness Use Criteria (Drilldown) Disclosures. Tony Hermann has nothing to disclose. Mark Hutcheson has nothing to disclose Appropriateness Use Criteria (Drilldown) Disclosures Tony Hermann has nothing to disclose Mark Hutcheson has nothing to disclose Connie Anderson has nothing to disclose Issam Moussa has nothing to disclose

More information

Appropriateness of Percutaneous Coronary Interventions in Washington State

Appropriateness of Percutaneous Coronary Interventions in Washington State Appropriateness of Percutaneous Coronary Interventions in Washington State Steven M. Bradley, Charles Maynard, Chris L. Bryson VA Puget Sound Healthcare System and University of Washington Presenter Disclosure

More information

Difficult Data Definitions and Scenario s

Difficult Data Definitions and Scenario s Difficult Data Definitions and Scenario s Presenter Disclosure Information Cornelia Anderson BSN, RN To following relationships exist related to this presentation: No Disclosures Objectives Discuss key

More information

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD Hein J. Verberne Academic Medical Center, University of Amsterdam, Amsterdam, Netherlands International Conference

More information

Treatment Options for Angina

Treatment Options for Angina Treatment Options for Angina Interventional Cardiology Perspective Michael A. Robertson, M.D. 10/30/10 Prevalence of CAD in USA 15 million Americans with CAD 2 million diagnostic catheterizations 1 million

More information

Guidelines/Appropriateness ARCH 2015 St Louis, Missouri April 9-11, 2015 Manish A. Parikh, MD, FACC,FSCAI

Guidelines/Appropriateness ARCH 2015 St Louis, Missouri April 9-11, 2015 Manish A. Parikh, MD, FACC,FSCAI Guidelines/Appropriateness ARCH 2015 St Louis, Missouri April 9-11, 2015 Manish A. Parikh, MD, FACC,FSCAI Center for Interventional Vascular Therapy Columbia University Medical Center / New York Presbyterian

More information

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine

Acute Coronary Syndrome. Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Acute Coronary Syndrome Cindy Baker, MD FACC Director Peripheral Vascular Interventions Division of Cardiovascular Medicine Topics Timing is everything So many drugs to choose from What s a MINOCA? 2 Acute

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio

David A. Orsinelli, MD, FACC, FASE Professor, Internal Medicine The Ohio State University Division of Cardiovascular Medicine Columbus, Ohio 1 STABLE ISCHEMIC HEART DISEASE: A NON-INVASIVE CARDIOLOGIST S PERSECTIVE 2018 Cardiovascular Course for Trainees and Early Career Physicians APRIL 20, 2018 David A. Orsinelli, MD, FACC, FASE Professor,

More information

What are the most common clinical scenarios that cause a PCI case to be deemed INAPPROPRIATE by AUC?

What are the most common clinical scenarios that cause a PCI case to be deemed INAPPROPRIATE by AUC? What are the most common clinical scenarios that cause a PCI case to be deemed INAPPROPRIATE by AUC? Michael A. Kutcher, MD, FSCAI Henry S. Jennings, III, MD, FSCAI The SCAI-Quality Improvement Toolkit

More information

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013 Disclosures Consultant- St Jude Medical Boston Scientific Speaker- Volcano Corporation Heart

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Efficiency Quality ID #323: Cardiac Stress Imaging t Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI) National Quality Strategy Domain: Efficiency and Cost Reduction

More information

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the

More information

Acute Coronary Syndrome. Sonny Achtchi, DO

Acute Coronary Syndrome. Sonny Achtchi, DO Acute Coronary Syndrome Sonny Achtchi, DO Objectives Understand evidence based and practice based treatments for stabilization and initial management of ACS Become familiar with ACS risk stratification

More information

Approach to Multi Vessel disease with STEMI

Approach to Multi Vessel disease with STEMI Approach to Multi Vessel disease with STEMI MANAGEMENT OF ST-ELEVATION MYOCARDIAL INFARCTION Dr. Thomas Alexander, M.D; D.M; F.A.C.C. Senior Consultant and Interventional Cardiologist Kovai Medical Centre

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association

NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki. 2013, American Heart Association NEBRASKA STEMI CONFERENCE 2015 Dr. Doug Kosmicki 2013, American Heart Association 1 Dr. Doug Kosmicki Reperfusion Strategies Disclosure Information Report any disclosure information of conflicts of interest.

More information

Acute Coronary Syndrome

Acute Coronary Syndrome Acute Coronary Syndrome Clinical Manifestation of CAD Silent Ischemia/asymptomatic Stable Angina Acute Coronary Syndrome (Non- STEMI/UA and STEMI) Arrhythmias Heart Failure Sudden Death Pain patterns with

More information

ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update

ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate Use Criteria for Coronary Revascularization Focused Update Journal of the American College of Cardiology Vol. 59, No. 9, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2011.12.001

More information

Journal of the American College of Cardiology Vol. 46, No. 8, by the American College of Cardiology Foundation ISSN /05/$30.

Journal of the American College of Cardiology Vol. 46, No. 8, by the American College of Cardiology Foundation ISSN /05/$30. Journal of the American College of Cardiology Vol. 46, No. 8, 2005 2005 by the American College of Cardiology Foundation ISSN 0735-1097/05/$30.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2005.08.029

More information

Decision for fibrinolysis or primary PCI in the prehospital phase

Decision for fibrinolysis or primary PCI in the prehospital phase Decision for fibrinolysis or primary PCI in the prehospital phase Nicolas Danchin, Hôpital Européen Georges Pompidou, Paris, France Disclosures Research grants: Astrazeneca, Eli-Lilly, GSK, Merck, Novartis,

More information

Disclosures. The Doctor in 2012: Quality, Accountability and Cost 5/30/2012. Challenges for the CV Profession

Disclosures. The Doctor in 2012: Quality, Accountability and Cost 5/30/2012. Challenges for the CV Profession Defining Appropriate Use of Percutaneous Coronary Revascularization in 2012 9 th Annual ACC Oregon Chapter Cardiovascular Symposium June 3, 2012 Ralph Brindis, MD, MPH, MACC, FSCAI Senior Advisor for Cardiovascular

More information

Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS

Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS Critics of Thrombolytics: Is Pre-Hospital Clot-busting Actually a Bad Thing? David Persse, MD Houston Fire Department EMS STEMI Stuff New or Recurrent MI s in U.S.: 865,000 Acute STEMI s: 500,000 Sooner

More information

Non ST Elevation-ACS. Michael W. Cammarata, MD

Non ST Elevation-ACS. Michael W. Cammarata, MD Non ST Elevation-ACS Michael W. Cammarata, MD Case Presentation 65 year old man PMH: CAD s/p stent in 2008 HTN HLD Presents with chest pressure, substernally and radiating to the left arm and jaw, similar

More information

PCI Guidelines: Essentials for Understanding the Appropriate Use Criteria. J. Jeffrey Marshall, MD, FSCAI

PCI Guidelines: Essentials for Understanding the Appropriate Use Criteria. J. Jeffrey Marshall, MD, FSCAI PCI Guidelines: Essentials for Understanding the Appropriate Use Criteria J. Jeffrey Marshall, MD, FSCAI December 8, 2013 Disclosures None PCI Guidelines: Essentials for Understanding the Appropriate

More information

Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy

Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy Recognizing the High Risk NSTEMI Patient for Early Appropriate Therapy Learning Objectives Learn to recognize the high risk patient Discuss effective management of a high risk NSTEMI patient Review CCS

More information

2018 Acute Coronary Syndrome. Robert Bender, DO, FACOI, FACC Central Maine Heart and Vascular Institute

2018 Acute Coronary Syndrome. Robert Bender, DO, FACOI, FACC Central Maine Heart and Vascular Institute 2018 Acute Coronary Syndrome Robert Bender, DO, FACOI, FACC Central Maine Heart and Vascular Institute Definitions: Acute Myocardial Ischemia Unstable Angina Non-ST-Elevation MI (NSTEMI) }2/3 ST-Elevation

More information

NCDR CathPCI Registry v4.4 Diagnostic Catheterization and Percutaneous Coronary Intervention Registry

NCDR CathPCI Registry v4.4 Diagnostic Catheterization and Percutaneous Coronary Intervention Registry A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - - SSN N/A 2031 Patient ID 2040 : (auto) Other ID 2045 : Birth Date 2050 : *** @ Sex 2060 : *** @ O Male O Female Race:

More information

Pharmaco-Invasive Approach for STEMI

Pharmaco-Invasive Approach for STEMI Pharmaco-Invasive Approach for STEMI Michael C. Kontos, MD Medical Director, Coronary Intensive Care Unit Director, Chest Pain Evaluation Center Associate Professor Departments of Internal Medicine (Cardiology),

More information

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM Version 4.4 Institutional Outcomes Report 2014Q3 National Outcomes Report 999997 Aggregation Date: Jan 12, 2015 11:59:59 PM Publish Date: Jan 29, 2015 If User desires to publish or otherwise distribute

More information

IABP SHOCK II trial:

IABP SHOCK II trial: IABP SHOCK II trial: Randomized comparison of intraaortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated by cardiogenic

More information

presenters 2010 Sameh Sabet Ain Shams University

presenters 2010 Sameh Sabet Ain Shams University Guidelines for PCI in late STEMI presenters 2010 Sameh Sabet Assistant Professor of Cardiology Ain Shams University 29% of MI patients have STEMI. NRMI 4 (Fourth National Registry of Myocardial Infarction),

More information

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet?

2/20/2013. Why use imaging in CV prevention? Update on coronary CTA in 2013 Coronary CTA for 1 0 prevention: pros and cons Are we there yet? Evolving Role of Coronary CTA in Primary Cardiovascular Disease Prevention: Are We There Yet? Ron Blankstein, M.D., F.A.C.C. Co-Director, Cardiovascular Imaging Training Program Associate Physician, Preventive

More information

Acute Coronary Syndrome

Acute Coronary Syndrome Acute Coronary Syndrome Vik Gongidi, DO FACOI, FACC Indian River Medical Center Vero Beach, FL Slides adapted from Robert Bender, DO, FACOI, FACC Definition: Acute Myocardial Ischemia Unstable Angina Non-ST-Elevation

More information

7. Echocardiography Appropriate Use Criteria (by Indication)

7. Echocardiography Appropriate Use Criteria (by Indication) Criteria for Echocardiography 1133 7. Echocardiography Criteria (by ) Table 1. TTE for General Evaluation of Cardiac Structure and Function Suspected Cardiac Etiology General With TTE 1. Symptoms or conditions

More information

DECLARATION OF CONFLICT OF INTEREST. Lecture fees: AstraZeneca, Ely Lilly, Merck.

DECLARATION OF CONFLICT OF INTEREST. Lecture fees: AstraZeneca, Ely Lilly, Merck. DECLARATION OF CONFLICT OF INTEREST Lecture fees: AstraZeneca, Ely Lilly, Merck. Risk of stopping dual therapy. S D Kristensen, FESC Aarhus Denmark Acute coronary syndrome: coronary thrombus Platelets

More information

FFR-CT Not Ready for Primetime

FFR-CT Not Ready for Primetime FFR-CT Not Ready for Primetime Leslee J. Shaw, PhD, MASNC, FACC, FAHA, FSCCT R. Bruce Logue Professor of Medicine Co-Director, Emory Clinical CV Research Institute Emory University School of Medicine Atlanta,

More information

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4 1 TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA FDA APPROVES IMPELLA FOR HIGH-RISK PCI 2 Impella is the only hemodynamic support device proven safe and effective in elective

More information

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO!

Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Can Angiographic Complete Revascularization Improve Outcomes for Patients with Decreased LV Function? NO! Young-Hak Kim, MD, PhD Heart Institute, University of Ulsan College of Medicine Asan Medical Center,

More information

Andreas Baumbach Bristol Heart Institute Bristol Royal Infirmary. London 27/1/2005

Andreas Baumbach Bristol Heart Institute Bristol Royal Infirmary. London 27/1/2005 Andreas Baumbach Bristol Heart Institute Bristol Royal Infirmary AB London 27/1/2005 Revascularisation in ACS ICTUS MERLIN REACT 4mins 4mins 4mins AB Tony s Comments 15mins ICTUS Comparison of an early

More information

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing

Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing Revascularization in Severe LV Dysfunction: The Role of Inducible Ischemia and Viability Testing Evidence and Uncertainties Robert O. Bonow, MD, MS, MACC Northwestern University Feinberg School of Medicine

More information

Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이

Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이 Role of echocardiography in the assessment of ischemic heart disease 분당서울대학교병원윤연이 Outline Evaluation of Chest pain Evaluation of MI complications Prediction of Outcomes Evaluation of Chest pain Evaluation

More information

Appropriate Timing for Coronary Revascularization Post - MI. Manesh R. Patel, MD Assistant Professor of Medicine Duke University Medical Center

Appropriate Timing for Coronary Revascularization Post - MI. Manesh R. Patel, MD Assistant Professor of Medicine Duke University Medical Center Appropriate Timing for Coronary Revascularization Post - M Manesh R. Patel, MD Assistant Professor of Medicine Duke University Medical Center Disclosures nterventional cardiologist Clinical Cardiovascular

More information

Rationale for Prophylactic Support During Percutaneous Coronary Intervention

Rationale for Prophylactic Support During Percutaneous Coronary Intervention Rationale for Prophylactic Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Assistant Director, Interventional Cardiology Director, Interventional Research Laboratories

More information

Emergency surgery in acute coronary syndrome

Emergency surgery in acute coronary syndrome Emergency surgery in acute coronary syndrome Teerawoot Jantarawan Division of Cardiothoracic Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand

More information

Cindy L. Grines MD FACC FSCAI

Cindy L. Grines MD FACC FSCAI Cindy L. Grines MD FACC FSCAI Hofstra Northwell School of Medicine Chair, Cardiology Academic Chief of Cardiology, Northwell Health North Shore University Hospital, Manhasset NY Multivessel Disease in

More information

Cardiac Arrhythmias in Acute Coronary Syndrome. Roj Rojjarekampai, MD Thammasart Hospital 26/5/59

Cardiac Arrhythmias in Acute Coronary Syndrome. Roj Rojjarekampai, MD Thammasart Hospital 26/5/59 Cardiac Arrhythmias in Acute Coronary Syndrome Roj Rojjarekampai, MD Thammasart Hospital 26/5/59 OUTLINE Management of tachy and brady-arrhytmia related ACS : AF : VA [ sustained VT /VF] : conduction disturbance

More information

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice

10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice 10-Year Mortality of Older Acute Myocardial Infarction Patients Treated in U.S. Community Practice Ajar Kochar, MD on behalf of: Anita Y. Chen, Puza P. Sharma, Neha J. Pagidipati, Gregg C. Fonarow, Patricia

More information

and Treatment in Emergency Care) Trial: Intravenous Glucose, Insulin & Potassium (GIK) in Emergency Medical Services

and Treatment in Emergency Care) Trial: Intravenous Glucose, Insulin & Potassium (GIK) in Emergency Medical Services Results of the IMMEDIATE (Immediate Myocardial Metabolic Enhancement DuringInitial Assessment and Treatment in Emergency Care) Trial: A Double Blinded Randomized Controlled Trial of Intravenous Glucose,

More information

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW Bruce Biccard Perioperative Research Group, Department of Anaesthetics 18 June 2015 Disclosure Research funding received Medical Research

More information

3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives

3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death Denise Pond BSN, RN The following relationships exist related to this presentation: No Disclosures Objectives Discuss

More information

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators

FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators FFR-guided Complete vs. Culprit Only Revascularization in AMI Patients Ki Hong Choi, MD On Behalf of FRAME-AMI Investigators Heart Vascular Stroke Institute, Samsung Medical Center, Seoul, Republic of

More information

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood

Revascularization In HFrEF: Are We Close To The Truth. Ali Almasood Revascularization In HFrEF: Are We Close To The Truth Ali Almasood HF epidemic 1-2% of the population have HF At least one-half have heart failure with reduced ejection fraction (HF- REF) The most common

More information

SBP in range of 120 to 140 :no progression or regression of CAD. Sipahi et al., 2006

SBP in range of 120 to 140 :no progression or regression of CAD. Sipahi et al., 2006 Management of Hypertension in Patients with CAD M. Mohsen Ibrahim, MD Cardiology Department- Cairo University 1. What is the optimal BP in patients with hypertension and CAD? 2. What is the minimum safe

More information

CathPCI Registry Poster Abstract

CathPCI Registry Poster Abstract CathPCI Registry Poster Abstract Topic of Poster: Quality Improvement Initiative Title: Process Improvement to Meet Appropriate Use Criteria (AUC) for Elective Patients in the National Cardiovascular Data

More information

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction

2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non ST-Elevation Myocardial Infarction Ramzi Khalil MD FACC Assistant Professor Allegheny Gen.Hospital AHN Speakers

More information

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease

Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 2012 대한춘계심장학회 Perioperative Cardiology Consultations for Noncardiac Surgery Ischemic Heart Disease 울산의대울산대학병원심장내과이상곤 ECG CLASS IIb 1. Preoperative resting 12-lead ECG may be reasonable in patients with

More information

CLINICAL SYMPTOMS AND ANGIOGRAPHIC FINDINGS OF PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOGRAPHY WITHOUT PRIOR STRESS TESTING. Mouin S.

CLINICAL SYMPTOMS AND ANGIOGRAPHIC FINDINGS OF PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOGRAPHY WITHOUT PRIOR STRESS TESTING. Mouin S. CLINICAL SYMPTOMS AND ANGIOGRAPHIC FINDINGS OF PATIENTS UNDERGOING ELECTIVE CORONARY ANGIOGRAPHY WITHOUT PRIOR STRESS TESTING BY Mouin S. Abdallah Submitted to the graduate degree program in Clinical research

More information

Controversies in Cardiac Pharmacology

Controversies in Cardiac Pharmacology Controversies in Cardiac Pharmacology Thomas D. Conley, MD FACC FSCAI Disclosures I have no relevant relationships with commercial interests to disclose. 1 Doc, do I really need to take all these medicines?

More information

Acute Coronary Syndromes: Different Continents, Different Guidelines?

Acute Coronary Syndromes: Different Continents, Different Guidelines? Acute Coronary Syndromes: Different Continents, Different Guidelines? Robert A. Harrington MD, MACC, FAHA, FESC Arthur L. Bloomfield Professor of Medicine Chair, Department of Medicine Stanford University

More information

PCI for Stable Ischemic Heart Disease: What Happened in the Last Week?

PCI for Stable Ischemic Heart Disease: What Happened in the Last Week? PCI for Stable Ischemic Heart Disease: What Happened in the Last Week? Ajay J. Kirtane, MD, SM Center for Interventional Vascular Therapy Columbia University Medical Center / NewYork Presbyterian Hospital

More information

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why? Screening for Asymptomatic Coronary Artery Disease: When, How, and Why? Joseph S. Terlato, MD FACC Clinical Assistant Professor, Brown Medical School Coastal Medical Definition The presence of objective

More information

Acute Coronary Syndromes

Acute Coronary Syndromes Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management

More information

The American College of Cardiology/American Heart

The American College of Cardiology/American Heart ACC/AHA/SCAI Practice Guideline ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention Summary Article A Report of the American College of Cardiology/American Heart Association Task

More information

Surgery Grand Rounds

Surgery Grand Rounds Surgery Grand Rounds Coronary Artery Bypass Grafting versus Coronary Artery Stenting Charles Ted Lord, R1 Coronary Artery Disease Stenosis of epicardial vessels Metabolic & hematologic Statistics 500,000

More information

DISCUSSION QUESTION - 1

DISCUSSION QUESTION - 1 CASE PRESENTATION 87 year old male No past history of diabetes, HTN, dyslipidemia or smoking Very active Medications: omeprazole for heart burn Admitted because of increasing retrosternal chest pressure

More information

Patient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization

Patient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization Patient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization + K Spargias, MD, PhD THV Director Hygeia Hospital Disclosures - Proctor

More information

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options?

Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? European Society of Cardiology Annual Session 2009 Management of ST-elevation myocardial infarction Update 2009 Late comers: which options? Antonio Abbate, MD Assistant Professor of Medicine Virginia Commonwealth

More information

Acute Circulatory Support Should We or Shouldn t We?

Acute Circulatory Support Should We or Shouldn t We? Acute Circulatory Support Should We or Shouldn t We? Navin K. Kapur, MD, FACC, FSCAI Assistant Professor, Division of Cardiology Director, Acute Circulatory Support Program Director, Interventional Research

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #323: Cardiac Stress Imaging Not Meeting Appropriate Use Criteria: Routine Testing After Percutaneous Coronary Intervention (PCI) National Quality Strategy Domain: Efficiency and Cost Reduction

More information

GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION. Pre-Hospital/Arrival

GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION. Pre-Hospital/Arrival GWTG-CAD: Mission: Lifeline Focus July 2017 PMT FORM SELECTION Page 1 Legend: BOLD = Required ^ = MLL Data Element Admin (Tab) ^Patient ID: Physician/Provider NPI: DOB: / / ^Arrival Date/Time: Race: Hispanic

More information

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None Inpatient Management of Non-ST Elevation Acute Coronary Syndromes Edward McNulty MD, FACC Assistant Clinical Professor UCSF Director, SF VAMC Cardiac Catheterization Laboratory Disclosures None New Guidelines

More information

Acute Coronary Syndromes. January 9, 2013 Chris Chiles M.D. FACC

Acute Coronary Syndromes. January 9, 2013 Chris Chiles M.D. FACC Acute Coronary Syndromes January 9, 2013 Chris Chiles M.D. FACC Disclosures None- not even a breakfast burrito from a drug company Hospitalizations in the U.S. Due to ACS Acute Coronary Syndromes* 1.57

More information

FFR? FFR-CT? Ischaemia testing?

FFR? FFR-CT? Ischaemia testing? FFR? FFR-CT? Ischaemia testing? Marco Zimarino, MD, PhD Institute of Cardiology - University G. d Annunzio, Chieti (Italy) Diagnostic management of patients with suspected stable CAD Risk stratification

More information

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction

2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction Developed in Collaboration with American College of Emergency Physicians and Society for Cardiovascular Angiography and

More information

Management of stable CAD FFR guided therapy: the new gold standard

Management of stable CAD FFR guided therapy: the new gold standard Management of stable CAD FFR guided therapy: the new gold standard Suleiman Kharabsheh, MD Director; CCU, Telemetry and CHU Associate professor of Cardiology, Alfaisal Univ. KFHI - KFSHRC Should patients

More information

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and

More information

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach

Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Current Advances and Best Practices in Acute STEMI Management A pharmacoinvasive approach Frans Van de Werf, MD, PhD University Hospitals, Leuven, Belgium Frans Van de Werf: Disclosures Research grants

More information

VHA Performance Measurement In Cardiac Care

VHA Performance Measurement In Cardiac Care VHA Performance Measurement In Cardiac Care A Map for VHA Cardiac Performance Measurement in FY 2005 and beyond Roxane Rusch, BSN, MPA, RN Department Of Veterans Affairs Office of Quality and Performance

More information

The Need for Rescue PCI after Failed Fibrinolysis: Who, When and Why.

The Need for Rescue PCI after Failed Fibrinolysis: Who, When and Why. Implementing the pharmacoinvasive strategy in STEMI The Need for Rescue PCI after Failed Fibrinolysis: Who, When and Why. 7:20-7:40 Robert C. Welsh, MD, FRCPC, FESC, FAHA, FACC Professor of Medicine Director,

More information

ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/ SCCT/SCMR/STS 2012 Appropriate Use Criteria for Diagnostic Catheterization

ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/ SCCT/SCMR/STS 2012 Appropriate Use Criteria for Diagnostic Catheterization Journal of the American College of Cardiology Vol. 59, No. 22, 2012 2012 by the American College of Cardiology Foundation ISSN 0735-1097/$36.00 Published by Elsevier Inc. doi:10.1016/j.jacc.2012.03.003

More information

The NICE chest pain guideline 1 year on. Jane S Skinner Consultant Community Cardiologist The Newcastle upon Tyne Hospitals NHS Foundation Trust

The NICE chest pain guideline 1 year on. Jane S Skinner Consultant Community Cardiologist The Newcastle upon Tyne Hospitals NHS Foundation Trust The NICE chest pain guideline 1 year on Jane S Skinner Consultant Community Cardiologist The Newcastle upon Tyne Hospitals NHS Foundation Trust The Society for Acute Medicine, 5 th International Conference,

More information

Chest Pain: To Cath or Not? Part I

Chest Pain: To Cath or Not? Part I Chest Pain: To Cath or Not? Part I Georgios Papaioannou, MD Ioannis Karavas, MD Newton-Wellesley Hospital 5/3/2000 1 A Typical Scenario... 57 year old female, Mrs. X., presents to your office with a 2

More information

Chest Pain. Dr Robert Huggett Consultant Cardiologist

Chest Pain. Dr Robert Huggett Consultant Cardiologist Chest Pain Dr Robert Huggett Consultant Cardiologist Outline Diagnosis of cardiac chest pain 2016 NICE update on stable chest pain Assessment of unstable chest pain/acs and MI definition Scope of the

More information

FastTest. You ve read the book now test yourself

FastTest. You ve read the book now test yourself FastTest You ve read the book...... now test yourself To ensure you have learned the key points that will improve your patient care, read the authors questions below. The answers will refer you back to

More information

Cardiogenic Shock. Carlos Cafri,, MD

Cardiogenic Shock. Carlos Cafri,, MD Cardiogenic Shock Carlos Cafri,, MD SHOCK= Inadequate Tissue Mechanisms: Perfusion Inadequate oxygen delivery Release of inflammatory mediators Further microvascular changes, compromised blood flow and

More information

Background. After PCI for MI, angina has important implications on quality of life and healthcare utilization

Background. After PCI for MI, angina has important implications on quality of life and healthcare utilization Angina Prevalence and Management for Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention: Insights from the TRANSLATE-ACS Study Alexander C. Fanaroff, Lisa A. Kaltenbach, Eric

More information

CCS/CAIC/CSCS Position Statement on Revascularization Multi-vessel CAD. Teo et al, Canadian Journal of Cardiology 2014;30:

CCS/CAIC/CSCS Position Statement on Revascularization Multi-vessel CAD. Teo et al, Canadian Journal of Cardiology 2014;30: CCS/CAIC/CSCS Position Statement on Revascularization Multi-vessel CAD Teo et al, Canadian Journal of Cardiology 2014;30: 1482-1491 Parallel Paper: Canadian Cardiovascular Society Guidelines for the Diagnosis

More information

The Role of Computed Tomography in the Diagnosis of Coronary Atherosclerosis

The Role of Computed Tomography in the Diagnosis of Coronary Atherosclerosis The Role of Computed Tomography in the Diagnosis of Coronary Atherosclerosis Saurabh Rajpal, MBBS, MD Assistant Professor Department of Internal Medicine Division of Cardiology The Ohio State University

More information

ASE 2011 Appropriate Use Criteria for Echocardiography

ASE 2011 Appropriate Use Criteria for Echocardiography ASE 2011 Appropriate Use Criteria for Echocardiography Table 1. TTE for General Evaluation of Cardiac Structure and Function 1 2 Suspected Cardiac Etiology General With TTE Symptoms or conditions potentially

More information

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

PCIs on Intermediate Lesions NCDR Cath-PCI Registry Practical Application Of Coronary Physiology in The Cath Lab Talal T Attar, MD, MBA, FACC PCIs on Intermediate Lesions NCDR Cath-PCI Registry Fraction of stenoses 50-70% treated with PCI without further

More information

3-year results of the OLIVE registry:

3-year results of the OLIVE registry: 3-year results of the OLIVE registry: A prospective multicenter study in patients with critical limb ischemia Osamu Iida, MD Kansai Rosai Hospital Cardiovascular Center Amagasaki, Hyogo, Japan Disclosure

More information

Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018

Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018 Choosing the Appropriate Stress Test: Brett C. Stoll, MD, FACC February 24, 2018 Choosing the Appropriate Stress Test: Does it Really Matter? Brett C. Stoll, MD, FACC February 24, 2018 Conflicts of Interest

More information

Fractional Flow Reserve: Review of the latest data

Fractional Flow Reserve: Review of the latest data Fractional Flow Reserve: Review of the latest data Michalis Hamilos, MD, PhD, FESC University Hospital of Heraklion Fractional Flow Reserve (FFR) Coronary angiography does not always tell the truth Most

More information

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction

Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Culprit PCI vs MultiVessel PCI for Acute Myocardial Infarction Dipti Itchhaporia, MD, FACC, FESC Trustee, American College of Cardiology Director of Disease Management, Hoag Hospital Robert and Georgia

More information

Guideline for STEMI. Reperfusion at a PCI-Capable Hospital

Guideline for STEMI. Reperfusion at a PCI-Capable Hospital MANSOURA. 2015 Guideline for STEMI Reperfusion at a PCI-Capable Hospital Mahmoud Yossof MANSOURA 2015 Reperfusion Therapy for Patients with STEMI *Patients with cardiogenic shock or severe heart failure

More information

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2

Objectives. Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 10/2013 1 Objectives Identify early signs and symptoms of Acute Coronary Syndrome Initiate proper protocol for ACS patient 10/2013 2 Purpose of this Education Module: Chest Pain Center Accreditation involves

More information

Acute Coronary Syndrome: Interventional Strategy

Acute Coronary Syndrome: Interventional Strategy 2005 Acute Coronary Syndrome: Interventional Strategy Youngkeun Ahn, MD, PhD, FACC, FSCAI Department of Cardiology Program in Gene and Cell Therapy, The Heart Center of Chonnam National University, GwangJu,,

More information

Ruhr-University Bochum, Germany. Ev. Stift St. Martin, Koblenz, Germany. Premier Heart, Port Washington, NY, USA

Ruhr-University Bochum, Germany. Ev. Stift St. Martin, Koblenz, Germany. Premier Heart, Port Washington, NY, USA Computerized resting ECG analysis for the detection of coronary artery stenosis after coronary revascularization in comparison with angiographic findings M. Imhoff 1, A. Bootsveld 2, J.T. Shen 3, S. Yuecel

More information

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention

Rationale for Left Ventricular Support During Percutaneous Coronary Intervention Rationale for Left Ventricular Support During Percutaneous Coronary Intervention Navin K. Kapur, MD, FACC, FSCAI Associate Professor, Division of Cardiology Director, Acute Circulatory Support Program

More information